Here are relevant reports on : endovascular-stents-market
-
Gastrointestinal Stent Market by Product (Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents and Esophageal Stents), Material (Self-Expanding Metal Stents and Plastic Stents), Application, End User & Region - Global Forecast to 2026
The size of global gastrointestinal stent market in terms of revenue was estimated to be worth $457 million in 2021 and is poised to reach $600 million by 2026, growing at a CAGR of 5.6% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: February 2022
- Price: $ 4950
- TOC Available:
-
Drug Eluting Stents Market - 2019 By Types, Application & Geography
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018
The North American interventional cardiology and peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S.
- Published: June 2014
- Price: $ 4950
- TOC Available:
-
Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices), End Users & Region - Global Forecast to 2026
The global peripheral vascular devices market in terms of revenue was estimated to be worth $10.3 billion in 2021 and is poised to reach $13.4 billion by 2026, growing at a CAGR of 5.3% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Angiographic Catheters Market by Application (Coronary, Endovascular, Neurology and Oncology), Geography (North America, Europe, Asia Pacific and Row), End-User Analysis (Reusage Scenario, Purchase Pattern) and Competitive Scenario - Global Forecast to 2022
Angiographic catheters market is expected to reach USD 1,402.8 million by 2022 from USD 922.1 million in 2016 and, at a CAGR of 7.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Increasing number of Cath labs in APAC, incidences of CVDs and preference for minimally invasive surgeries are few of the reasons for the growth of this market
- Published: April 2018
- Price: $ 4950
- TOC Available:
-
Interventional Radiology Products Market Size, Share & Trends by type (Stents, Catheters, IVC Filter, Biopsy Needles, Embolization Devices, Accessories), Procedure Type (Angioplasty, Angiography, Thrombolysis, Embolization), Applications (Oncology) - Global Forecast to 2026
The size of global interventional radiology products market in terms of revenue was estimated to be worth USD 10.2 billion in 2021 and is poised to reach USD 14.1 billion by 2026, growing at a CAGR of 6.6% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Bioabsorbable Stents Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022
The global bioresorbable stents market is projected to reach USD 417.2 Million by 2022, at a CAGR of 11.5%. Market growth of bioresorbable stents is attributed to the growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies. However, factors such as the increasing product withdrawals due to severe complications of these stents may hamper market growth. The bioresorbable stents screening market is a niche market with the presence of several emerging players and few big players. Prominent players in the market include Abbott (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Airway Stent/Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecasts to 2024
The lung stent market is projected to reach USD 120 million by 2024, at a CAGR of 6.7%. The major players operating in the lung stent market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Interventional Cardiology Devices Market Size, Share & Trends by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) & Region - Global Forecast to 2027
The size of global interventional cardiology devices market in terms of revenue was estimated to be worth USD 17.5 billion in 2022 and is poised to reach USD 25.5 billion by 2027, growing at a CAGR of 7.7% from 2022 to 2027. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: January 2021
- Price: $ 4950
- TOC Available:
-
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
- Published: June 2013
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50